Taylor Rohan, Galvez Veronica, Loo Colleen
Health Education & Training Institute, Gladesville, NSW, Research Fellow, School of Psychiatry and Black Dog Institute, University of New South Wales, Randwick, NSW; Psychiatry Registrar, Concord Centre for Mental Health, Concord, NSW, Australia.
Psychiatrist, School of Psychiatry, University of New South Wales, Randwick, NSW; Black Dog Institute, University of New South Wales, Randwick, NSW, Australia.
Australas Psychiatry. 2018 Apr;26(2):189-192. doi: 10.1177/1039856217748249. Epub 2018 Jan 17.
Repetitive transcranial magnetic stimulation (rTMS) is increasingly being utilised as a treatment option for depression, and with this comes a need for a practical review of safety issues intended for clinicians. This article provides an overview of the current literature regarding safety issues with rTMS for depression, and provides recommendations for clinical practice.
Overall, rTMS is a well-tolerated treatment with common side effects (such as headache or local pain at the site of stimulation) being mild. Severe adverse effects, such as seizures, hearing impairment or mania, are uncommon. Certain populations, including adolescents, pregnant women, older adults and those with metal/electronic implants, require special consideration when prescribing and monitoring treatment courses. With adequate assessment and monitoring processes, rTMS can be administered safely in a large proportion of depressed patients.
重复经颅磁刺激(rTMS)越来越多地被用作抑郁症的一种治疗选择,因此需要为临床医生提供一份关于安全问题的实用综述。本文概述了当前有关rTMS治疗抑郁症安全问题的文献,并为临床实践提供建议。
总体而言,rTMS是一种耐受性良好的治疗方法,常见副作用(如头痛或刺激部位局部疼痛)较轻。严重不良反应,如癫痫发作、听力障碍或躁狂症并不常见。在开处方和监测治疗过程时,某些人群,包括青少年、孕妇、老年人以及有金属/电子植入物的人,需要特别考虑。通过充分的评估和监测程序,rTMS可以在很大一部分抑郁症患者中安全使用。